Value £950,000

Invizius

VC Funding

Series A Angel-backed

Healthcare & Biotech Published 24 September 2024

Summary

In a significant market movement during September 2024, Invizius was the subject of a vc funding. The transaction achieved a gross valuation of £950,000. Leading the round was Syensqo, the University of Edinburgh's Old College Capital, Calculus Capital, Scottish Enterprise, Mercia Ventures.

This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.

Lead Investor / Acquirer

Syensqo

Lead Investor / Acquirer

the University of Edinburgh's Old College Capital

Lead Investor / Acquirer

Calculus Capital

Lead Investor / Acquirer

Scottish Enterprise

Lead Investor / Acquirer

Mercia Ventures

Advising Broker

Undisclosed Firm

Related Deals in Healthcare & Biotech

Series A prioritised

VC Funding

Luna Pet Healthcare

£700,000

May 2026

VC Funding

Koalaa

£941,985

Feb 2024

VC Funding

Newcells Biotech

£2,350,000

Feb 2024

VC Funding

TalkLife

Undisclosed

Feb 2024

View Company Details

Financials, officers, full deal history

Original Source

This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.

View on Tech.eu Funding Explorer

Funding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.

AI Insight Lenses

Pro

AI-generated analysis from four professional perspectives. Powered by PE Deals.

Free to all registered users.